학술논문

A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours
Document Type
Journal
Source
BRITISH JOURNAL OF CANCER; OCT 6 2020, 8p.
Subject
Language
English
ISSN
15321827